We chose this RKO-based model in the first instance because, although colon-cancer-derived, it is near-diploid, karyotypically stable44 with precisely defined and regulatable MYC status, making it a tractable system to establish experimental parameters including drug exposure concentrations and time-courses. Here, MYC is linked to colonic neoplasm.